Clinical Trial Update: Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and immunogenicity of a freeze-dried rabies vaccine produced in MRC-5 cells in Chinese participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Freeze-dried Rabies Vaccine (MRC-5 Cell) (rabies vaccine, MRC-5 cell line)

Snippet

Sponsor: Beijing Center for Disease Control and Prevention | Conditions: Safety, Immunogenicity | Phase 3 | Status: COMPLETED